Novel microbiome signatures for non‐invasive diagnosis of adenoma recurrence after colonoscopic polypectomy

Summary Background We previously reported a panel of novel faecal microbiome gene markers for diagnosis of colorectal adenoma and cancer. Aim To evaluate whether these markers are useful in detecting adenoma recurrence after polypectomy. Methods Subjects were enrolled in a polyp surveillance study f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2022-04, Vol.55 (7), p.847-855
Hauptverfasser: Liang, Jessie Qiaoyi, Zeng, Yao, Kwok, Grace, Cheung, Chun Pan, Suen, Bing Yee, Ching, Jessica Y. L., To, Ka Fai, Yu, Jun, Chan, Francis K. L., Ng, Siew Chien
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background We previously reported a panel of novel faecal microbiome gene markers for diagnosis of colorectal adenoma and cancer. Aim To evaluate whether these markers are useful in detecting adenoma recurrence after polypectomy. Methods Subjects were enrolled in a polyp surveillance study from 2009 to 2019. Stool samples were collected before bowel preparation of index colonoscopy (baseline) and surveillance colonoscopy (follow‐up). Fusobacterium nucleatum (Fn), Lachnoclostridium marker (m3), Clostridium hathewayi (Ch) and Bacteroides clarus were quantified in baseline and follow‐up samples by quantitative polymerase chain reaction (qPCR) to correlate with adenoma recurrence. Recurrence was defined as new adenomas detected >6 months after polypectomy. Faecal immunochemical test (FIT) was performed for comparison. Results A total of 161 baseline and 104 follow‐up samples were analysed. Among patients with adenoma recurrence, Fn and m3 increased (both P 
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.16799